Antag Therapeutics ApS

Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professors Mette Rosenkilde and Jens Juul Holst have discovered naturally occurring therapeutic peptides that are being investigated in several human studies.

Our mission is to develop first-in-class peptide drugs for the treatment of dietary-related metabolic diseases. Our drugs are based on a novel, effective, naturally occurring antagonist that modulates fat deposition and dysregulation of glycemia in diabetic patients.

Contact name:

Alexander Sparre-Ulrich, CEO

Address:

Ole Maaløes vej 3 DK 2200 København N

Telephone:

21456537

Established:

2017

Number of employees:

4

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2018 Danskbiotek. All rights reserved.